Magnetic Seizure Therapy (MST) for the Treatment of Major Depression

Completed · Phase 2

Conditions studied: Major Depressive Disorder

In brief

This two-center, between-subject, randomized, double-masked study (n=20) will provide the first evidence for the antidepressant efficacy of Magnetic Seizure Therapy (MST) and contrast the therapeutic properties and side effects of two forms of MST in patients in a major depressive episode (MDE).

Key facts

Study ID
NCT00973934
Run by
Sarah Lisanby
People needed
20
Starts
2002-04-01
Expected to finish
2009-12-01
Last updated by the study team
2014-06-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.